Immediate Impact

1 from Science/Nature 53 standout
Sub-graph 1 of 25

Citing Papers

Lung cancer statistics, 2023
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
3 intermediate papers

Works of L Buffoni being referenced

Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario
2017
BIBF 1120/nintedanib: a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
L Buffoni 486 314 183 49 791
Maurizio Mezzetti 517 239 162 36 929
Sung Jun 359 288 52 83 736
Mutlay Sayan 366 156 208 81 825
Hani Ashamalla 363 267 192 67 973
Jianguo Sun 320 410 278 57 878
Lei Yin 394 449 79 37 799
Jennifer A. Dorth 259 331 159 60 779
Michael Kuettel 355 125 231 51 815
Quynh‐Nhu Nguyen 383 429 106 54 952
M. Herbst 460 214 94 58 810

All Works

Loading papers...

Rankless by CCL
2026